BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22847234)

  • 1. Comparative expression profiling identifies differential roles for Myogenin and p38α MAPK signaling in myogenesis.
    Liu QC; Zha XH; Faralli H; Yin H; Louis-Jeune C; Perdiguero E; Pranckeviciene E; Muñoz-Cànoves P; Rudnicki MA; Brand M; Perez-Iratxeta C; Dilworth FJ
    J Mol Cell Biol; 2012 Dec; 4(6):386-97. PubMed ID: 22847234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
    Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
    Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMAD2 promotes myogenin expression and terminal myogenic differentiation.
    Lamarche É; AlSudais H; Rajgara R; Fu D; Omaiche S; Wiper-Bergeron N
    Development; 2021 Feb; 148(3):. PubMed ID: 33462116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MURC, a muscle-restricted coiled-coil protein, is involved in the regulation of skeletal myogenesis.
    Tagawa M; Ueyama T; Ogata T; Takehara N; Nakajima N; Isodono K; Asada S; Takahashi T; Matsubara H; Oh H
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C490-8. PubMed ID: 18508909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway.
    Murray J; Huss JM
    Am J Physiol Cell Physiol; 2011 Sep; 301(3):C630-45. PubMed ID: 21562305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation.
    Perdiguero E; Ruiz-Bonilla V; Gresh L; Hui L; Ballestar E; Sousa-Victor P; Baeza-Raja B; Jardí M; Bosch-Comas A; Esteller M; Caelles C; Serrano AL; Wagner EF; Muñoz-Cánoves P
    EMBO J; 2007 Mar; 26(5):1245-56. PubMed ID: 17304211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic deficiency of p38alpha reveals its critical role in myoblast cell cycle exit: the p38alpha-JNK connection.
    Perdiguero E; Ruiz-Bonilla V; Serrano AL; Muñoz-Cánoves P
    Cell Cycle; 2007 Jun; 6(11):1298-303. PubMed ID: 17534150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-183-5p induced by saturated fatty acids regulates the myogenic differentiation by directly targeting FHL1 in C2C12 myoblasts.
    Nguyen MT; Min KH; Lee W
    BMB Rep; 2020 Nov; 53(11):605-610. PubMed ID: 33148375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin-wide and transcriptome profiling integration uncovers p38α MAPK as a global regulator of skeletal muscle differentiation.
    Segalés J; Islam AB; Kumar R; Liu QC; Sousa-Victor P; Dilworth FJ; Ballestar E; Perdiguero E; Muñoz-Cánoves P
    Skelet Muscle; 2016; 6():9. PubMed ID: 26981231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TBP-like protein (TLP) represses myogenesis via inhibition of the myogenin promoter.
    Nakazato A; Maeda R; Ishikawa K; Suzuki H; Tamura TA
    Biochem Biophys Res Commun; 2016 Oct; 479(4):814-819. PubMed ID: 27680312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of myogenin on muscle fiber types and key metabolic enzymes in gene transfer mice and C2C12 myoblasts.
    Zhu LN; Ren Y; Chen JQ; Wang YZ
    Gene; 2013 Dec; 532(2):246-52. PubMed ID: 24055422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mitochondrial micropeptide MPM enhances mitochondrial respiratory activity and promotes myogenic differentiation.
    Lin YF; Xiao MH; Chen HX; Meng Y; Zhao N; Yang L; Tang H; Wang JL; Liu X; Zhu Y; Zhuang SM
    Cell Death Dis; 2019 Jul; 10(7):528. PubMed ID: 31296841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin is a key regulator of myoblast differentiation.
    Lee EJ; Bhat AR; Kamli MR; Pokharel S; Chun T; Lee YH; Nahm SS; Nam JH; Hong SK; Yang B; Chung KY; Kim SH; Choi I
    PLoS One; 2013; 8(5):e63627. PubMed ID: 23717457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myogenin is required for assembly of the transcription machinery on muscle genes during skeletal muscle differentiation.
    Adhikari A; Kim W; Davie J
    PLoS One; 2021; 16(1):e0245618. PubMed ID: 33465133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKCθ signaling is required for myoblast fusion by regulating the expression of caveolin-3 and β1D integrin upstream focal adhesion kinase.
    Madaro L; Marrocco V; Fiore P; Aulino P; Smeriglio P; Adamo S; Molinaro M; Bouché M
    Mol Biol Cell; 2011 Apr; 22(8):1409-19. PubMed ID: 21346196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teashirt-3, a novel regulator of muscle differentiation, associates with BRG1-associated factor 57 (BAF57) to inhibit myogenin gene expression.
    Faralli H; Martin E; Coré N; Liu QC; Filippi P; Dilworth FJ; Caubit X; Fasano L
    J Biol Chem; 2011 Jul; 286(26):23498-510. PubMed ID: 21543328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role for p38alpha MAPK but not p38gamma MAPK in Igf2 expression and myoblast differentiation.
    Lovett FA; Cosgrove RA; Gonzalez I; Pell JM
    Endocrinology; 2010 Sep; 151(9):4368-80. PubMed ID: 20610565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA Neat1 modulates myogenesis by recruiting Ezh2.
    Wang S; Zuo H; Jin J; Lv W; Xu Z; Fan Y; Zhang J; Zuo B
    Cell Death Dis; 2019 Jun; 10(7):505. PubMed ID: 31243262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SMYD3 methyltransferase promotes myogenesis by activating the myogenin regulatory network.
    Codato R; Perichon M; Divol A; Fung E; Sotiropoulos A; Bigot A; Weitzman JB; Medjkane S
    Sci Rep; 2019 Nov; 9(1):17298. PubMed ID: 31754141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size.
    Knapp JR; Davie JK; Myer A; Meadows E; Olson EN; Klein WH
    Development; 2006 Feb; 133(4):601-10. PubMed ID: 16407395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.